rs147649203
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_000328.3(RPGR):āc.2323A>Gā(p.Ile775Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000205 in 1,207,803 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 65 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_000328.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPGR | NM_000328.3 | c.2323A>G | p.Ile775Val | missense_variant | 19/19 | NP_000319.1 | ||
RPGR | NM_001367245.1 | c.2320A>G | p.Ile774Val | missense_variant | 19/19 | NP_001354174.1 | ||
RPGR | NM_001367246.1 | c.2137A>G | p.Ile713Val | missense_variant | 18/18 | NP_001354175.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENSG00000250349 | ENST00000465127.1 | c.172-396370T>C | intron_variant | 5 | ENSP00000417050.1 |
Frequencies
GnomAD3 genomes AF: 0.000286 AC: 32AN: 111944Hom.: 0 Cov.: 23 AF XY: 0.000235 AC XY: 8AN XY: 34084
GnomAD3 exomes AF: 0.000191 AC: 35AN: 183156Hom.: 0 AF XY: 0.000177 AC XY: 12AN XY: 67686
GnomAD4 exome AF: 0.000197 AC: 216AN: 1095805Hom.: 0 Cov.: 29 AF XY: 0.000158 AC XY: 57AN XY: 361287
GnomAD4 genome AF: 0.000286 AC: 32AN: 111998Hom.: 0 Cov.: 23 AF XY: 0.000234 AC XY: 8AN XY: 34148
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 06, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 17, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at